Genome-wide Analysis of for the Identification of Putative Therapeutic Targets

Ever increasing propensity of antibiotic resistance among pathogenic bacteria raises the demand for the development of novel therapeutic agents to control this grave problem. Advances in the field of bioinformatics, genomics, and proteomics have greatly facilitated the discovery of alternative drugs...

Full description

Saved in:
Bibliographic Details
Main Authors: Md. Masud Parvege (Author), Monzilur Rahman (Author), Mohammad Shahnoor Hossain (Author)
Format: Book
Published: AboutScience Srl, 2014-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c7ccb0bdc66843f081ae2f73d8cecab5
042 |a dc 
100 1 0 |a Md. Masud Parvege  |e author 
700 1 0 |a Monzilur Rahman  |e author 
700 1 0 |a Mohammad Shahnoor Hossain  |e author 
245 0 0 |a Genome-wide Analysis of for the Identification of Putative Therapeutic Targets 
260 |b AboutScience Srl,   |c 2014-01-01T00:00:00Z. 
500 |a 1177-3928 
500 |a 10.4137/DTI.S19728 
520 |a Ever increasing propensity of antibiotic resistance among pathogenic bacteria raises the demand for the development of novel therapeutic agents to control this grave problem. Advances in the field of bioinformatics, genomics, and proteomics have greatly facilitated the discovery of alternative drugs by swift identification of new drug targets. In the present study, we employed comparative genomics and metabolic pathway analysis with an aim of identifying therapeutic targets in Mycoplasma hominis. Our study has revealed 40 annotated metabolic pathways, including five unique pathways of M. hominis. Our study also identified 179 essential proteins, including 59 proteins having no similarity with human proteins. Further filtering by molecular weight, subcellular localization, functional analysis, and protein network interaction, we identified 57 putative candidates for which new drugs can be developed. Druggability analysis for each of the identified targets has prioritized 16 proteins as suitable for potential drug development. 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Drug Target Insights, Vol 8 (2014) 
787 0 |n https://doi.org/10.4137/DTI.S19728 
787 0 |n https://doaj.org/toc/1177-3928 
856 4 1 |u https://doaj.org/article/c7ccb0bdc66843f081ae2f73d8cecab5  |z Connect to this object online.